Our focused, lean approach is uniquely tailored to help our clients accelerate access to their products in this country.
TORONTO, Ontario (PRWEB) January 30, 2020
Accelera Canada, a full-service firm delivering end-to-end commercialization services to emerging biotechnology ventures with an eye on the Canadian market, is pleased to announce that the company has opened the doors of its first office in Toronto, following two successful years of growth since the company launched in 2017.
“We are so thrilled to now have all our partners and their highly skilled teams under one roof, to further enhance our one-of-a-kind integrated approach to unlocking the value of Canada’s private and public markets for our clients, and bringing life-changing global healthcare innovation to patients in this country,” said Michael Cloutier, Founding Partner of Accelera Canada.
In the past two years, the firm has enabled several global biotechnology companies to gain entry to the growing Canadian healthcare market, and successfully launch their products by determining their optimal “go-to market” strategy and supporting on-the-ground implementation.
“Our unparalleled team of strategists represents the only firm in Canada with a proven track record of experienced CEOs and functional area experts in every essential aspect of product commercialization,” said Deborah Brown, Accelera Canada’s Managing Partner. “Our focused, lean approach is uniquely tailored to help our clients accelerate access to their products in this country.”
About Accelera Canada
Accelera Canada is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. With senior leadership comprised of former pharmaceutical executives with North American and global experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market.
For more information please contact: